Showing results (1451-1460 of 5,686) with videos related to
Sort By:
Pageof 569
Drug Design, Development and Therapy|April 7, 2016
Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in miceDubravka Svob Strac, Josipa Vlainic, Janko Samardzic, et al.Drug Design, Development and Therapy|March 12, 2016
Total saponin of Dioscoreae hypoglaucae rhizoma ameliorates streptozotocin-induced diabetic nephropathyChangrun Guo, Gang Ding, Wenzhe Huang, et al.Drug Design, Development and Therapy|March 12, 2016
The mechanism underlying alpinetin-mediated alleviation of pancreatitis-associated lung injury through upregulating aquaporin-1Xingsi Liang, Bin Zhang, Quan Chen, et al.Drug Design, Development and Therapy|July 3, 2013
Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot studyShih-Lung Cheng, Hao-Chien Wang, Sow-Hsong KuoDrug Design, Development and Therapy|July 3, 2013
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanibHannah V Woodcock, Philip L Molyneaux, Toby M MaherDrug Design, Development and Therapy|July 31, 2013
Organelle targeting: third level of drug targetingNiraj M Sakhrani, Harish PadhDrug Design, Development and Therapy|December 31, 2014
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathwayTao Ren, Jinlu Shan, Yi Qing, et al.Drug Design, Development and Therapy|December 31, 2014
Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal studyJunhui Su, Cui Chang, Qi Xiang, et al.Drug Design, Development and Therapy|January 2, 2015
Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathwayJin-Lian He, Zhi-Wei Zhou, Juan-Juan Yin, et al.Drug Design, Development and Therapy|January 2, 2015
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)Rudolph M NavariPageof 569